Does ISTRADEFYLLINE Cause Mobility decreased? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Mobility decreased have been filed in association with ISTRADEFYLLINE (NOURIANZ). This represents 0.4% of all adverse event reports for ISTRADEFYLLINE.
21
Reports of Mobility decreased with ISTRADEFYLLINE
0.4%
of all ISTRADEFYLLINE reports
1
Deaths
1
Hospitalizations
How Dangerous Is Mobility decreased From ISTRADEFYLLINE?
Of the 21 reports, 1 (4.8%) resulted in death, 1 (4.8%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ISTRADEFYLLINE. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does ISTRADEFYLLINE Cause?
Death (571)
Drug ineffective (551)
Hallucination (462)
Dyskinesia (428)
Dizziness (387)
Condition aggravated (384)
Constipation (317)
Product dose omission issue (299)
Fall (260)
Therapy non-responder (251)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which ISTRADEFYLLINE Alternatives Have Lower Mobility decreased Risk?
ISTRADEFYLLINE vs ITACITINIB
ISTRADEFYLLINE vs ITRACONAZOLE
ISTRADEFYLLINE vs ITRACONAZOLE\SODIUM
ISTRADEFYLLINE vs IVABRADINE
ISTRADEFYLLINE vs IVACAFTOR